Cases & Deals

  • Home
  • Practices
  • Boehringer Ingelheim Pharmaceuticals evaluates antibody patents

Share

Boehringer Ingelheim Pharmaceuticals evaluates antibody patents

October 2015

Client(s) Boehringer Ingelheim Pharmaceuticals, Inc.

Jones Day represents Boehringer Ingelheim Pharmaceuticals, Inc. in evaluating patents, including antibody-related patents, with respect to validity and infringement, and other issues.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.